Intellia Therapeutics Stock Forecast

Stock Price Forecast

The 18 analysts with 12-month price forecasts for Intellia Therapeutics stock have an average target of 39.44, with a low estimate of 11 and a high estimate of 90. The average target predicts an increase of 388.72% from the current stock price of 8.07.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$11	$39.44	$41	$90
Change	+36.31%	+388.72%	+408.05%	+1015.2%

Analyst Ratings

The average analyst rating for Intellia Therapeutics stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	5	5	5	5	5	6
Buy	7	7	7	7	6	6
Hold	5	5	5	6	6	6
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	17	17	17	18	17	18

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $30	Strong Buy	Initiates	$30	+271.75%	Mar 5, 2025
Joon Lee Truist Securities	Truist Securities	Strong Buy Maintains $90 → $50	Strong Buy	Maintains	$90 → $50	+519.58%	Mar 4, 2025
Gena Wang Barclays	Barclays	Buy Maintains $55 → $26	Buy	Maintains	$55 → $26	+222.18%	Feb 28, 2025
David Lebowitz Citigroup	Citigroup	Hold Maintains $12 → $14	Hold	Maintains	$12 → $14	+73.48%	Feb 28, 2025
Yanan Zhu Wells Fargo	Wells Fargo	Buy Maintains $60 → $50	Buy	Maintains	$60 → $50	+519.58%	Feb 28, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

50.15M

from 57.88M

-13.35%

from 57.88M

Revenue Next Year

46.00M

from 50.15M

-8.28%

from 50.15M

EPS This Year

-4.75

from -5.25

EPS Next Year

-4.62

from -4.75

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	57.99M	33.05M	52.12M	36.28M	57.88M	50.15M	46.00M	423.58M
Revenue Growth	34.55%	-43.01%	57.69%	-30.40%	59.55%	-13.35%	-8.28%	820.85%
EPS	-2.40	-3.78	-6.16	-5.42	-5.25	-4.75	-4.62	-4.07
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	29	27	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	220.5M	105.0M	4.0B
Avg	50.1M	46.0M	423.6M
Low	n/a	6.9M	3.6M

Revenue Growth

Revenue Growth	2025	2026	2027
High	281.0%	109.4%	8,543.7%
Avg	-13.4%	-8.3%	820.8%
Low	-	-86.3%	-92.2%

EPS Forecast

EPS	2025	2026	2027
High	-3.35	-3.03	-3.06
Avg	-4.75	-4.62	-4.07
Low	-5.60	-5.56	-5.08

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.